Abstract
Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD) is an ultra-rare autosomal recessive neurometabolic disorder caused by ALDH5A1 mutations presenting with autism and epilepsy. Here, we report the generation and characterization of human induced pluripotent stem cells (hiPSCs) derived from fibroblasts of three unrelated SSADHD patients - one female and two males with the CRISPR-corrected isogenic controls. These individuals are clinically diagnosed and are being followed in a longitudinal clinical study.
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, N.I.H., Extramural
MeSH terms
-
Amino Acid Metabolism, Inborn Errors / genetics
-
Amino Acid Metabolism, Inborn Errors / pathology
-
CRISPR-Cas Systems
-
Cell Line
-
Clustered Regularly Interspaced Short Palindromic Repeats / genetics
-
Developmental Disabilities
-
Female
-
Humans
-
Induced Pluripotent Stem Cells* / metabolism
-
Male
-
Succinate-Semialdehyde Dehydrogenase* / deficiency
-
Succinate-Semialdehyde Dehydrogenase* / genetics
-
Succinate-Semialdehyde Dehydrogenase* / metabolism
Substances
-
Succinate-Semialdehyde Dehydrogenase
Supplementary concepts
-
succinic semialdehyde dehydrogenase deficiency